Vasculopathy and amyloid beta reactivity in brains of patients with acquired immune deficiency (AIDS)
- PMID: 11693722
Vasculopathy and amyloid beta reactivity in brains of patients with acquired immune deficiency (AIDS)
Abstract
The authors examined multiple brain sections from 15 autopsy cases of AIDS for the vascular changes, presence of amyloid plaques and signs of axonal damage. The mean patients age was 33.8 years (range 24-48 years). Neuropathological findings included: HIV-specific changes (5), opportunistic infections (7), lymphoma (1) and two cases with nonspecific changes. All sections were stained with hematoxylin-eosin (H-E), selected sections were stained with Masson trichrome, Gomori reticulin, Congo red and thioflavine S method. Two sections from each case were immunostained for the presence of beta-amyloid (4G8). ubiquitin, alpha-smooth muscle actin and CD31. The different forms of vascular changes were found in all cases. The common changes were: lymphocytic perivascular or transmural infiltrations and hyalinization, thickening or fibrosis of the arterial and arteriolar wall. The perivascular space widening up to status lacunaris was a frequent phenomenon in the basal ganglia and deep white matter. Some of the cortical arterioles formed little multiluminal structures. Immunohistochemical examination revealed features of hypertrophy of the vascular muscular layer and signs of the slight endothelial cells proliferation. In three cases 4G8 immunopositive. Congo red and thioflavine S-negative, diffuse beta-amyloid deposits were present in the gray matter, focally their localization was perivascular. Ubiquitin immunoreactivity presented as numerous dot-like structures or focal bundles of positive widened axons in the white matter, spheroids and scattered positive neurons were also found. The authors suggest that some of morphological changes within the brain and consecutive neuropsychological symptoms in AIDS are of the vascular origin. Presence of amyloid plaques and axonal damage are the elements of the complex degenerative and inflammatory process in the brain caused by chronic inflammatory stimulation in HIV infection.
Similar articles
-
Brain biopsy in Indiana AIDS patients.Indiana Med. 1993 Mar-Apr;86(2):158-61. Indiana Med. 1993. PMID: 8463645
-
Opportunistic infections of the central nervous system in the course of acquired immune deficiency syndrome (AIDS). Morphological analysis of 172 cases.Folia Neuropathol. 1998;36(3):129-44. Folia Neuropathol. 1998. PMID: 9833390
-
Pathological findings correlated with MRI in HIV infection.Neuroradiology. 1993;35(4):264-8. doi: 10.1007/BF00602609. Neuroradiology. 1993. PMID: 8388082
-
Clinical and biologic features of the AIDS dementia complex.Neuroimaging Clin N Am. 1997 Aug;7(3):581-92. Neuroimaging Clin N Am. 1997. PMID: 9376969 Review.
-
The neuropathology of adult HIV infection.Rev Neurol (Paris). 1998 Dec;154(12):816-29. Rev Neurol (Paris). 1998. PMID: 9932303 Review.
Cited by
-
Risk of developing cerebral β-amyloid plaques with posttranslational modification among HIV-infected adults.AIDS. 2019 Nov 15;33(14):2157-2166. doi: 10.1097/QAD.0000000000002336. AIDS. 2019. PMID: 31688040 Free PMC article.
-
Associations of regional amyloid-β plaque and phospho-tau pathology with biological factors and neuropsychological functioning among HIV-infected adults.J Neurovirol. 2019 Dec;25(6):741-753. doi: 10.1007/s13365-019-00761-y. Epub 2019 May 29. J Neurovirol. 2019. PMID: 31144289 Free PMC article.
-
Aneurysm formation and postcoiling recurrence in HIV-associated vasculopathy: illustrative case.J Neurosurg Case Lessons. 2025 Mar 3;9(9):CASE24700. doi: 10.3171/CASE24700. Print 2025 Mar 3. J Neurosurg Case Lessons. 2025. PMID: 40030146 Free PMC article.
-
Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers.AIDS. 2012 Nov 28;26(18):2327-35. doi: 10.1097/QAD.0b013e32835a117c. AIDS. 2012. PMID: 23018443 Free PMC article.
-
Tat peptides inhibit neprilysin.J Neurovirol. 2006 Jun;12(3):153-60. doi: 10.1080/13550280600760677. J Neurovirol. 2006. PMID: 16877296